Back to Search Start Over

Author response for 'Tirzepatide vs. Semaglutide for Weight Loss In Patients With Type 2 Diabetes Mellitus ‐ A Value For Money Analysis'

Authors :
null Joseph Azuri
null Ariel Hammerman
null Enis Aboalhasan
null Ben Sluckis
null Ronen Arbel
Publication Year :
2022
Publisher :
Wiley, 2022.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........d8eabb8856cb8cd2ae4558852fbfc41f
Full Text :
https://doi.org/10.1111/dom.14940/v2/response1